Business Segments and Geographic Information (Tables)

12 Months Ended

Sep. 28, 2024

Segment information for fiscal 2024, 2023, and 2022 was as follows:


	Years Ended
	September 28, 2024		September 30, 2023		September 24, 2022
Total revenues:
Diagnostics	$	1,782.0	$	1,880.1	$	3,018.5
Breast Health	1,522.9		1,432.7		1,227.8
GYN Surgical	641.3		604.2		522.9
Skeletal Health	84.1		113.4		93.6
	$	4,030.3	$	4,030.4	$	4,862.8
Operating income (loss):
Diagnostics	$	303.1	$	193.9	$	1,359.4
Breast Health	394.5		273.0		183.2
GYN Surgical	185.5		188.9		104.9
Skeletal Health	(0.5)		12.6		(7.3)
	$	882.6	$	668.4	$	1,640.2
Depreciation and amortization:
Diagnostics	$	218.8	$	224.7	$	274.0
Breast Health	41.6		50.0		58.8
GYN Surgical	48.1		48.0		96.6
Skeletal Health	0.5		0.7		0.7
	$	309.0	$	323.4	$	430.1
Capital expenditures:
Diagnostics	$	80.2	$	85.2	$	96.8
Breast Health	30.9		41.1		14.6
GYN Surgical	16.6		17.0		12.8
Skeletal Health	1.4		0.8		0.3
Corporate	1.1		6.1		2.7
	$	130.2	$	150.2	$	127.2
Identifiable assets:
Diagnostics	$	2,431.3	$	2,596.4	$	2,881.7
Breast Health	1,588.9		1,170.1		1,245.8
GYN Surgical	1,419.9		1,455.4		1,461.5
Skeletal Health	48.3		33.7		27.5

Corporate	3,667.6		3,883.7		3,454.7
	$	9,156.0	$	9,139.3	$	9,071.2

Revenues by geography as a percentage of total revenues were as follows:

The Company’s property, plant and equipment were geographically located as follows: